<ol class="cite-this-references"><li id="reference-A190189">Bekker A, Kloepping C, Collingwood S: Meloxicam in the management of post-operative pain: Narrative review. J Anaesthesiol Clin Pharmacol. 2018 Oct-Dec;34(4):450-457. doi: 10.4103/joacp.JOACP_133_18. [<a href="/articles/A190189" target="_blank">Article</a>] </li><li id="reference-A190192">Moore RA, Derry S, McQuay HJ: Single dose oral meloxicam for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007552. doi: 10.1002/14651858.CD007552.pub2. [<a href="/articles/A190192" target="_blank">Article</a>] </li><li id="reference-A190195">Turck D, Roth W, Busch U: A review of the clinical pharmacokinetics of meloxicam. Br J Rheumatol. 1996 Apr;35 Suppl 1:13-6. doi: 10.1093/rheumatology/35.suppl_1.13. [<a href="/articles/A190195" target="_blank">Article</a>] </li><li id="reference-A190198">Katz JA: COX-2 inhibition: what we learned--a controversial update on safety data. Pain Med. 2013 Dec;14 Suppl 1:S29-34. doi: 10.1111/pme.12252. [<a href="/articles/A190198" target="_blank">Article</a>] </li><li id="reference-A190201">Seddik H, Rabhi M: [Meloxicam-induced colitis revealed by acute abdominal pain]. Ann Pharm Fr. 2013 Mar;71(2):119-22. doi: 10.1016/j.pharma.2012.12.003. Epub 2013 Mar 8. [<a href="/articles/A190201" target="_blank">Article</a>] </li><li id="reference-A14902">Chesne C, Guyomard C, Guillouzo A, Schmid J, Ludwig E, Sauter T: Metabolism of Meloxicam in human liver involves cytochromes P4502C9 and 3A4. Xenobiotica. 1998 Jan;28(1):1-13. doi: 10.1080/004982598239704. [<a href="/articles/A14902" target="_blank">Article</a>] </li><li id="reference-A176366">Ricciotti E, FitzGerald GA: Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011 May;31(5):986-1000. doi: 10.1161/ATVBAHA.110.207449. [<a href="/articles/A176366" target="_blank">Article</a>] </li><li id="reference-A39443">Prasad GS, Srisailam K, Sashidhar RB: Metabolic inhibition of meloxicam by specific CYP2C9 inhibitors in Cunninghamella blakesleeana NCIM 687: in silico and in vitro studies. Springerplus. 2016 Feb 24;5:166. doi: 10.1186/s40064-016-1794-4. eCollection 2016. [<a href="/articles/A39443" target="_blank">Article</a>] </li><li id="reference-T757">Carl P. Weiner MD, MBA, FACOG, Clifford Mason PhD (2019). Drugs for Pregnant and Lactating Women (3rd ed.). Elsevier. </li><li id="reference-L11398">FDA approved products: Mobic (meloxicam) oral tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020938s024s025,021530s014s015lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11470">Medsafe NZ: Mobictab (meloxicam) oral tablets [<a href="https://www.medsafe.govt.nz/profs/Datasheet/m/Mobictab.pdf" target="_blank">Link</a>] </li><li id="reference-L11473">American College of Cardiology: Meloxicam [<a href="https://www.cardiosmart.org/Healthwise/d045/32/d04532" target="_blank">Link</a>] </li><li id="reference-L34100">FDA Approved Drug Products: ZYNRELEF (bupivacaine and meloxicam) extended-release solution for injection [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/211988s005lbl.pdf" target="_blank">Link</a>] </li></ol>